Nautilus Biotechnology, Inc.

Developing a proteomics platform for single-molecule analysis to advance life sciences research.

NAUT | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 2701 EASTLAKE AVE EAST, 98102 SEATTLE
Website:: https://www.nautilus.bio/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Nautilus Biotechnology, Inc. is a development-stage life sciences company focused on revolutionizing the field of proteomics. The company is creating a platform to analyze and quantify the human proteome with single-molecule resolution at a massive scale. Its proprietary technology leverages a method called Iterative Mapping to provide high-resolution views of billions of individual protein molecules and their modified forms (proteoforms). Nautilus aims to democratize proteomics by offering an integrated system with accessible workflows and cloud-based analysis tools. The platform is designed to accelerate breakthroughs in drug discovery, biomarker identification, and fundamental biological research by providing clearer insights into the mechanisms of health and disease.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nautilus Biotechnology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nautilus Biotechnology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Nautilus Biotechnology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CHAMPIONS ONCOLOGY, INC. Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.	United States of America	CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.	United States of America	CRL
Ch. Charilaou Group Plc A tour operator selling travel packages and developing online reservation platform solutions.	Cyprus	CHCH
Cheil Worldwide Inc Creates data-driven, integrated marketing and connected experiences for global brands.	South Korea	030000
Chiome Bioscience Inc. Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.	Japan	4583
Chordia Therapeutics,Inc Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.	Japan	190A
CHOSA Oncology AB Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.	Sweden	CHOSA
Cidara Therapeutics, Inc. Developing drug-Fc conjugates as targeted immunotherapies for cancer and serious infections.	United States of America	CDTX
CINC Corp. Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.	Japan	4378
CIRCULATION Co.,Ltd. Connects corporations with experts for project-based consulting to solve business challenges.	Japan	7379